Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for
Glioblastoma
Location: Houston TX, Columbia MO, Atlanta GA, Louisville KY,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase 3, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Houston TX, Sugar Land TX, Cypress TX, Nassau Bay TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase 3, Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Houston TX, Temple TX, Birmingham AL, St. Petersburg FL,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906640

Recruiting

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

for
Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T-Cell
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0 - 70+

Code: NCT06345027

Phase 1, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Houston TX, Sugar Land TX, Cypress TX, Nassau Bay TX,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis (gMG)
Location: Houston TX, Kansas City KS, Jacksonville FL, Aurora CO,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 70

Code: NCT06359041

Phase 1, Phase 2, Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Houston TX, The Woodlands TX, Austin TX, Tyler TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Houston TX, Temple TX, Dallas TX, Pine Bluff AR,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase 2, Phase 3, Recruiting

VoiceLove Digital Therapy for Delirium in the ICU

for
Delirium
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07218484

Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Houston TX, Memphis TN, Iowa City IA, Aurora CO,
Sponsor: University of Iowa

Sex: All

Age: 0+

Code: NCT01193088

Recruiting

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor

for
Upper Limb Essential Tremor
Location: Houston TX, Dallas TX, Frisco TX, Memphis TN,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07673107

Phase 2, Recruiting

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

for
Metastatic Neoplasm
Location: Houston TX, Chicago IL, Hackensack NJ
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07030712

Phase 1, Recruiting

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

for
Prostate Cancer (Adenocarcinoma)
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: Male

Age: 40+

Code: NCT07182279

Phase 1, Phase 2, Recruiting

EVERO Drug-coated Balloon (DCB) Randomized Trial

for
Peripheral Vascular Disease, Peripheral Arterial Disease
Location: Houston TX, Humble TX, Dallas TX, Tupelo MS,
Sponsor: Cook Research Incorporated

Sex: All

Age: 18+

Code: NCT07144150

Recruiting

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: Houston TX, Austin TX, San Antonio TX, Plano TX,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase 2, Phase 3, Recruiting

Bone Stimulator for Spondylolysis

for
Spondylolysis, Symptomatic Spondylolysis, Athletes
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 16 - 40

Code: NCT06666608

Recruiting

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

for
Hepatoblastoma, Hepatocellular Carcinoma, Wilms Tumor,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0 - 21

Code: NCT06198296

Phase 1, Recruiting

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

for
Ischemic Heart Disease (IHD),
Location: Houston TX, Nashville TN, Louisville KY, Charlotte NC,
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 35 - 70+

Code: NCT06854458

Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: Houston TX, Fort Worth TX, Oklahoma City OK, Tulsa OK,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Houston TX, Webster TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City